Subscribe to our newsletter to receive the latest product updates and special offers

HomeNewsScreenerMapsGroupsPortfolioInsiderFuturesForexCryptoBacktestsElite
Theme 		Help
Order by Signal Tickers
Filters
Overview Valuation Financial Ownership Performance Technical ETF ETF Perf Custom Charts Tickers Basic TA News Snapshot Maps Stats
#11 / 200 Total
ICLK - iClick Interactive Asia Group Ltd ADR - Stock Price Chart
TickerICLK [NASD]
CompanyiClick Interactive Asia Group Ltd ADR
CountryHong Kong
IndustryAdvertising Agencies
Market Cap10.85MEPS (ttm)-
P/E-EPS this Y-
Forward P/E-EPS next Y-
PEG-EPS past 5Y-13.13%
P/S-EPS next 5Y-
P/B0.26EPS Q/Q-2045.94%
Dividend-Sales Q/Q-44.28%
Insider Own-Inst Own12.35%
Insider Trans-Inst Trans-6.77%
Short Float0.03%EarningsDec 13/b
Analyst Recom3.00Target Price4.00
Avg Volume17.23K52W Range1.36 - 4.01
Today 08:00AM iClick Interactive Asia Group Limited Announces Termination of Merger Agreement (PR Newswire) -50.99%
Mar-28-24 06:40AM iClick Appoints Ms. Josephine Ngai as Chief Financial Officer (PR Newswire)
Mar-08-24 08:45AM iClick Interactive Asia Group Limited Announces Shareholders' Approval of Merger Agreement (PR Newswire)
Feb-01-24 04:25PM iClick Interactive Asia Group Limited to Hold Extraordinary General Meeting of Shareholders (PR Newswire)
Dec-13-23 02:53PM ICLK Stock Earnings: iClick Interactive Asia Reported Results for H1 2023 (InvestorPlace)
09:18AM iClick Interactive Asia Group Limited Reports 2023 Half-Year Unaudited Financial Results (PR Newswire)
Nov-29-23 07:30AM iClick Interactive Asia Group Limited Schedules 2023 Annual General Meeting for December 29, 2023 (PR Newswire)
Nov-24-23 07:15AM iClick Interactive Asia Group Limited Enters into a Definitive Merger Agreement for Going-Private Transaction (PR Newswire) +27.33%
Aug-24-23 12:00AM iClick Interactive Bolsters Partnership with Xiaohongshu to Capture Overseas Opportunities (PR Newswire)
May-11-23 04:40PM iClick Interactive Asia Group Limited Files 2022 Annual Report on Form 20-F (PR Newswire) +8.70%
IFBD - Infobird Co Ltd - Stock Price Chart
TickerIFBD [NASD]
CompanyInfobird Co Ltd
CountryChina
IndustrySoftware - Application
Market Cap6.57MEPS (ttm)-6.69
P/E-EPS this Y-
Forward P/E-EPS next Y-
PEG-EPS past 5Y-
P/S2.24EPS next 5Y-
P/B3.60EPS Q/Q97.28%
Dividend-Sales Q/Q-100.00%
Insider Own0.14%Inst Own0.23%
Insider Trans0.00%Inst Trans-
Short Float7.67%Earnings-
Analyst Recom1.00Target Price9976.00
Avg Volume884.73K52W Range3.44 - 395.20
Mar-06-24 08:10AM Why Is Infobird (IFBD) Stock Up 63% Today? (InvestorPlace) +45.89%
Feb-27-24 08:05AM Why Is Infobird (IFBD) Stock Up Today? (InvestorPlace) -53.62%
Feb-26-24 12:00PM Infobird Co., Ltd Announces Delay in Effective Date of Reverse Split to March 4 ,2024 (PR Newswire) -26.98%
Feb-20-24 11:15AM Infobird Co., Ltd Announces 1-for-8 Share Consolidation and Capital Reduction (PR Newswire)
Feb-16-24 08:30AM INFOBIRD CO., LTD ANNOUNCES THE SUSPENSION OF CAPITAL RAISING IN THE NEXT THREE MONTHS (PR Newswire) +27.89%
Feb-01-24 08:46AM Why Is Infobird (IFBD) Stock Down 31% Today? (InvestorPlace) -25.74%
Dec-19-23 08:08AM Why Is Infobird (IFBD) Stock Up 62% Today? (InvestorPlace) -8.49%
Dec-18-23 05:00PM INFOBIRD CO., LTD ANNOUNCES NEW BUSINESS COOPERATION IN INFORMATION TECHNOLOGY SYSTEM SOFTWARE DEVELOPMENT (PR Newswire)
Dec-07-23 05:00PM Infobird Co., Ltd Regains Compliance with Nasdaq Minimum Bid Price Requirement (PR Newswire)
Nov-16-23 08:00AM Infobird Co., Ltd Announces 1-for-20 Share Consolidation and Increase of Authorized Share Capital (PR Newswire)
PROK - ProKidney Corp - Stock Price Chart
TickerPROK [NASD, RUT]
CompanyProKidney Corp
CountryUSA
IndustryBiotechnology
Market Cap130.63MEPS (ttm)-0.57
P/E-EPS this Y-66.75%
Forward P/E-EPS next Y35.14%
PEG-EPS past 5Y-
P/S-EPS next 5Y-
P/B-EPS Q/Q9.68%
Dividend-Sales Q/Q-
Insider Own29.67%Inst Own57.35%
Insider Trans-35.43%Inst Trans2.18%
Short Float26.67%EarningsMar 21/a
Analyst Recom1.80Target Price4.20
Avg Volume707.33K52W Range1.12 - 13.51
Mar-25-24 06:05AM ProKidney Announces Key Leadership Appointments Strengthening Clinical and Technical Operations (GlobeNewswire)
Mar-21-24 07:49PM ProKidney Reports Full Year 2023 Financial Results and Recent Corporate Highlights (GlobeNewswire) -6.16%
Feb-29-24 04:05PM ProKidney to Participate in Jefferies Biotech on the Bay Summit (GlobeNewswire)
Dec-29-23 08:22AM Chamath Palihapitiya Stocks: 12 Stocks Pumped in the Last 10 Years (Insider Monkey)
Dec-13-23 09:55AM Here's Why ProKidney Corp. (PROK) Is a Great 'Buy the Bottom' Stock Now (Zacks) +9.60%
Nov-30-23 06:05AM ProKidney Appoints Nikhil Pereira-Kamath, MBA, as Chief Business Officer (GlobeNewswire) -10.16%
Nov-24-23 06:40AM 7 Penny Stocks With Low Floats and High Short Interest (InvestorPlace)
Nov-21-23 06:05AM ProKidney to Participate in a Fireside Chat at the Upcoming Evercore ISI 6th Annual HEALTHCONx Conference (GlobeNewswire) +5.68%
Nov-17-23 01:38PM ProKidney Corp. (NASDAQ:PROK) Q3 2023 Earnings Call Transcript (Insider Monkey)
Nov-16-23 09:35AM After Plunging -37.39% in 4 Weeks, Here's Why the Trend Might Reverse for ProKidney Corp. (PROK) (Zacks) -11.51%
AGEN - Agenus Inc - Stock Price Chart
TickerAGEN [NASD, RUT]
CompanyAgenus Inc
CountryUSA
IndustryBiotechnology
Market Cap244.91MEPS (ttm)-13.88
P/E-EPS this Y43.81%
Forward P/E-EPS next Y-66.54%
PEG-EPS past 5Y13.79%
P/S1.57EPS next 5Y-
P/B-EPS Q/Q51.04%
Dividend-Sales Q/Q195.22%
Insider Own4.95%Inst Own54.20%
Insider Trans102.53%Inst Trans-
Short Float12.99%EarningsMay 07/b
Analyst Recom1.20Target Price88.75
Avg Volume678.82K52W Range4.78 - 42.60
Apr-24-24 10:00AM Botensilimab/Balstilimab Data in MSS CRC Selected for the American Society of Clinical Oncology 2024 Annual Meeting (Business Wire) +14.86%
Apr-23-24 07:30AM Agenus to Provide First Quarter 2024 Financial Report and Corporate Update (Business Wire) +11.96%
Apr-22-24 04:17AM Agenus (AGEN) Soars 6.8%: Is Further Upside Left in the Stock? (Zacks) +8.66%
Apr-12-24 07:30AM Agenus Announces Updated Phase 1 Data and Progress on BOT/BAL Development in Metastatic MSS Colorectal Cancer (Business Wire) -8.12%
Apr-08-24 03:34AM Down 75%. Is Agenus Stock a Buy on the Dip? (Motley Fool) -7.58%
Apr-05-24 04:30PM Agenus Announces Reverse Stock Split of Common Stock (Business Wire)
Apr-03-24 04:19AM 2 Stocks That Could More Than Double Your Money, According to Wall Street: Are They Buys Now? (Motley Fool)
Mar-24-24 04:05PM 3 Mind-Blowing Stocks That Could Turn $1,000 Into $1 Million (InvestorPlace)
Mar-22-24 01:25PM MiNK Therapeutics, Inc. (NASDAQ:INKT) Q4 2023 Earnings Call Transcript (Insider Monkey)
Mar-15-24 02:11PM Agenus Inc. (NASDAQ:AGEN) Q4 2023 Earnings Call Transcript (Insider Monkey) -9.95%
AILE - iLearningEngines Inc. - Stock Price Chart
TickerAILE [NASD]
CompanyiLearningEngines Inc.
CountryUSA
IndustryShell Companies
Market Cap93.04MEPS (ttm)-0.39
P/E-EPS this Y-
Forward P/E-EPS next Y-
PEG-EPS past 5Y-
P/S-EPS next 5Y-
P/B4.18EPS Q/Q30.77%
Dividend-Sales Q/Q-
Insider Own62.67%Inst Own33.92%
Insider Trans0.00%Inst Trans1.38%
Short Float0.19%Earnings-
Analyst Recom1.00Target Price18.00
Avg Volume23.76K52W Range6.55 - 20.00
Apr-22-24 04:30PM iLearningEngines Reports Fourth Quarter and Full Year 2023 Results (GlobeNewswire)
Apr-18-24 06:30PM Nationwide Insurance to Showcase How they are Driving Proactive Risk Management Using iLearningEngines' Enterprise AI Platform at the 2024 Insurance Innovators Conference (GlobeNewswire) -28.90%
Apr-17-24 09:20AM iLearningEngines, Inc. Announces Additional Funding in Connection With Its Business Combination; Brings Gross Proceeds to Approximately $92.8 Million (GlobeNewswire) -44.44%
Apr-16-24 04:05PM iLearningEngines, Inc. Becomes Publicly Traded Company After Completing Business Combination With Arrowroot Acquisition Corp., Will Commence Trading on Nasdaq Under Ticker Symbol AILE (GlobeNewswire) +45.04%
Apr-01-24 04:05PM Arrowroot Acquisition Corp. Shareholders Approve Previously Announced Business Combination With iLearningEngines, Inc. (Business Wire) +19.82%
Mar-28-24 11:00AM iLearningEngines, Inc. to Add Michael Moe and Sir Ian Davis to its Board of Directors (Business Wire)
Mar-26-24 09:18PM Arrowroot Acquisition Corp. Announces Postponement of Special Meeting of Stockholders (PR Newswire) -13.50%
Mar-22-24 04:53PM Arrowroot Acquisition Corp. Announces Postponement of Special Meeting of Stockholders (PR Newswire)
Mar-13-24 04:15PM Arrowroot Acquisition Corp. Announces Postponement of Special Meeting of Stockholders and New Record Date of Special Meeting of Stockholders (PR Newswire)
Feb-28-24 10:05AM Hillsinai Learning, in Partnership With Vedhik AI Schools, Selects iLearningEngines as Its AI Learning Automation Platform (Business Wire)
STI - Solidion Technology Inc - Stock Price Chart
TickerSTI [NASD]
CompanySolidion Technology Inc
CountryUSA
IndustryElectrical Equipment & Parts
Market Cap199.87MEPS (ttm)-3.66
P/E-EPS this Y-
Forward P/E-EPS next Y-
PEG-EPS past 5Y-
P/S-EPS next 5Y2.60%
P/B-EPS Q/Q-9438.89%
Dividend-Sales Q/Q-
Insider Own86.91%Inst Own1.47%
Insider Trans0.00%Inst Trans0.59%
Short Float4.16%EarningsApr 12/b
Analyst Recom-Target Price-
Avg Volume4.50M52W Range0.37 - 13.85
Apr-12-24 09:00AM Solidion Technology Reports Results for Full Year 2023 (GlobeNewswire) -7.67%
Mar-18-24 08:14AM Why Is Solidion Technology (STI) Stock Up 55% Today? (InvestorPlace) +56.32%
Mar-13-24 09:08PM Solidion Technology, Inc. Announces Pricing of $3.85 Million Private Placement (GlobeNewswire) -13.19%
Mar-11-24 04:12PM Why Is Solidion Technology (STI) Stock Up 125% Today? (InvestorPlace) +125.75%
Mar-06-24 09:00AM Solidion Technologys Lithium-Sulfur Batteries on a Launch Pad to Accelerate the Takeoff of the eVTOL Aircraft Industry (GlobeNewswire)
Feb-27-24 09:00AM Extending the Driving Range without Increasing EV Weight? Yes, Solidion Technology, Inc. Provides Solutions (GlobeNewswire) -5.12%
Feb-20-24 09:00AM Solidion Technology, Inc. Provides Drop-in Solutions to the Production of Solid-State Batteries (GlobeNewswire) -7.79%
Feb-15-24 04:30PM Solidion Technology Inc. Ready to Produce Sustainable Graphite Anode Materials, a Key Component in Lithium-ion Batteries (GlobeNewswire) -13.58%
RENB - Renovaro Inc. - Stock Price Chart
TickerRENB [NASD]
CompanyRenovaro Inc.
CountryUSA
IndustryBiotechnology
Market Cap219.82MEPS (ttm)-0.65
P/E-EPS this Y-
Forward P/E-EPS next Y-
PEG-EPS past 5Y-19.64%
P/S-EPS next 5Y-
P/B2.36EPS Q/Q14.32%
Dividend-Sales Q/Q-
Insider Own28.97%Inst Own1.76%
Insider Trans0.00%Inst Trans-1.58%
Short Float2.16%Earnings-
Analyst Recom-Target Price-
Avg Volume311.95K52W Range0.39 - 5.25
Apr-24-24 09:00AM RenovaroCube to Acquire 100% Ownership of Cyclomics, Reinforcing Cutting-Edge Cancer Diagnostics Partnership (GlobeNewswire)
Apr-18-24 08:45AM Renovaro Inc. Proudly Announces the Appointment Of Professor Dr. Geert Kazemier as the Chairman of its Scientific Advisory Board, A Move That Heralds a New Era of Innovation and Progress in its Mission to Reshape Cancer Screening, Diagnosis, and Patient Care (GlobeNewswire)
Mar-04-24 09:00PM Bragar Eagel & Squire, P.C. Is Investigating Waldencast, Chemours, Trupanion, and Renovaro and Encourages Investors to Contact the Firm (GlobeNewswire) +12.99%
Feb-15-24 09:25AM Cutting Edge AI Company GEDiCube and Cyclomics sign binding LOI to join forces and position themselves at the forefront of the global liquid biopsy marketplace (GlobeNewswire) -8.68%
Feb-14-24 10:01AM Statement of Renovaro Inc (GlobeNewswire) +14.06%
Feb-13-24 09:46AM Cutting Edge AI Company GEDiCube and Cyclomics sign binding LOI to join forces and position themselves at the forefront of the global liquid biopsy marketplace (GlobeNewswire) -42.86%
09:31AM AI Pioneer GEDi Cube and Biotech Innovator Renovaro Biosciences Combine Forces to Accelerate Personalized Medicine (GlobeNewswire)
Jan-25-24 12:45PM Renovaro Biosciences Announces Results of Special Meeting of Shareholders (GlobeNewswire) +7.38%
Jan-18-24 09:30AM Renovaro BioSciences Releases CEO Shareholder Message (NewMediaWire)
Jan-16-24 08:00AM Message from Renovaro Bioscience, Inc.'s CEO, The Hon. Mark Dybul, MD (GlobeNewswire)
ZVSA - ZyVersa Therapeutics Inc - Stock Price Chart
TickerZVSA [NASD]
CompanyZyVersa Therapeutics Inc
CountryUSA
IndustryBiotechnology
Market Cap37.87MEPS (ttm)-71.31
P/E-EPS this Y98.62%
Forward P/E-EPS next Y-206.98%
PEG-EPS past 5Y-
P/S-EPS next 5Y-
P/B0.18EPS Q/Q-6291.81%
Dividend-Sales Q/Q-
Insider Own1.17%Inst Own13.75%
Insider Trans0.00%Inst Trans21.31%
Short Float0.61%EarningsMar 25/b
Analyst Recom1.00Target Price80.00
Avg Volume246.92K52W Range5.00 - 220.85
Apr-04-24 07:57AM ZyVersa Therapeutics Highlights Published Data Demonstrating NLRP3 Inflammasome Inhibition Has Potential to Decrease Atherosclerotic Lesions in Patients with Diabetes (GlobeNewswire)
Mar-25-24 08:17AM ZyVersa Therapeutics Reports Full Year 2023 Financial Results and Provides Business Update (GlobeNewswire)
Mar-18-24 07:57AM ZyVersa Therapeutics Announces IRB Approval of Phase 2a Clinical Trial Protocol to Evaluate Cholesterol Efflux Mediator VAR 200 in Patients with Diabetic Kidney Disease (GlobeNewswire) +8.79%
Mar-14-24 07:57AM ZyVersa Therapeutics' CEO, Stephen C. Glover to Participate in a Panel Discussion Titled Inflammation Illuminated, at Benzinga's Virtual Healthcare Summit 2024 on March 20, 2024 (GlobeNewswire)
Feb-29-24 07:57AM ZyVersa Therapeutics Generated Approximately $2.7 Million From Exercise of Warrants Following Excitement Around News That Inflammasome Inhibitors Have Potential to Effectively Treat Obesity (GlobeNewswire) +10.00%
Feb-28-24 07:57AM ZyVersa Therapeutics Highlights Data from Review Article Published in Nature Reinforcing IC 100's Rationale for Inhibiting ASC and ASC Specks to Attenuate Damaging Inflammation Associated with Various Conditions, Including Obesity and Its Complications (GlobeNewswire) -8.26%
Feb-26-24 07:55AM Why Is ZyVersa Therapeutics (ZVSA) Stock Up 37% Today? (InvestorPlace) +34.83%
Feb-22-24 07:47AM ZyVersa Therapeutics Publishes New White Paper Detailing the Role of Inflammasomes and ASC Specks in Neurological Diseases, and Data Supporting Inflammasome ASC Inhibitor IC 100 as a Potential Therapeutic Option (GlobeNewswire)
Feb-14-24 07:53AM ZyVersa Therapeutics Highlights Review Article Substantiating That Inflammasome Activation Is Pathogenic in Multiple Neurological Diseases (GlobeNewswire)
Feb-07-24 08:02AM ZyVersa Therapeutics' CEO, Stephen C. Glover to Present at the 2024 BIO CEO & Investor Conference to Provide Corporate Update and Discuss Key Milestones (GlobeNewswire)
ATOM - Atomera Inc - Stock Price Chart
TickerATOM [NASD, RUT]
CompanyAtomera Inc
CountryUSA
IndustrySemiconductor Equipment & Materials
Market Cap119.70MEPS (ttm)-0.77
P/E-EPS this Y25.00%
Forward P/E-EPS next Y41.67%
PEG-EPS past 5Y4.74%
P/S210.01EPS next 5Y20.00%
P/B6.50EPS Q/Q12.68%
Dividend-Sales Q/Q-
Insider Own4.83%Inst Own31.84%
Insider Trans-2.83%Inst Trans1.12%
Short Float18.78%EarningsApr 25/a
Analyst Recom1.00Target Price13.00
Avg Volume221.75K52W Range4.96 - 10.72
Today 07:01PM Atomera Inc (ATOM) (Q1 2024) Earnings Call Transcript Highlights: Navigating Financials and ... (GuruFocus.com) -17.13%
02:00AM Atomera (ATOM) Q1 2024 Earnings Call Transcript (Motley Fool)
Apr-25-24 08:56PM ATOM Stock Earnings: Atomera Misses EPS for Q1 2024 (InvestorPlace) -5.79%
06:12PM Atomera Inc (ATOM) Reports Q1 2024 Earnings: A Closer Look Against Analyst Projections (GuruFocus.com)
04:01PM Atomera Provides First Quarter 2024 Results (ACCESSWIRE)
Apr-15-24 04:05PM Atomera to Announce First Quarter 2024 Financial Results and Host Webinar on Thursday, April 25, 2024 (ACCESSWIRE)
Mar-06-24 02:55PM 3 Top Hypergrowth Stocks Primed to Steal the Spotlight (InvestorPlace)
Feb-22-24 05:05PM Media Alert: Atomera to Present Joint Paper with Soitec and San Jose State University on Advanced RF Technologies at 8th IEEE Electronic Devices Technology and Manufacturing (EDTM) Conference 2024 (Business Wire)
Feb-14-24 08:52AM Atomera Incorporated (NASDAQ:ATOM) Q4 2023 Earnings Call Transcript (Insider Monkey) -13.44%
Feb-13-24 10:00PM Atomera (ATOM) Q4 2023 Earnings Call Transcript (Motley Fool) -9.38%
RWOD - Redwoods Acquisition Corp - Stock Price Chart
TickerRWOD [NASD]
CompanyRedwoods Acquisition Corp
CountryUSA
IndustryShell Companies
Market Cap13.06MEPS (ttm)0.11
P/E68.32EPS this Y-
Forward P/E-EPS next Y-
PEG-EPS past 5Y-
P/S-EPS next 5Y-
P/B3.42EPS Q/Q-64.17%
Dividend-Sales Q/Q-
Insider Own39.65%Inst Own88.99%
Insider Trans0.00%Inst Trans-
Short Float0.60%Earnings-
Analyst Recom-Target Price-
Avg Volume167.60K52W Range4.98 - 13.10
Apr-19-24 10:25AM RWOD Stock: 7 Things to Know About the Anew Medical Merger (InvestorPlace) +26.05%
07:57AM Why Is Redwoods Acquisition (RWOD) Stock Up 72% Today? (InvestorPlace)
Mar-04-24 05:00AM ANEW MEDICAL ANNOUNCES KEY PATENT ISSUED IN CHINA TO PROTECT KLOTHO PROTEIN AND GENE DELIVERY SYSTEMS (PR Newswire)
Jun-06-23 06:30AM ANEW MEDICAL, INC. (OTC: LEAS) and Redwoods Acquisition Corp. (NASDAQ: RWOD) Entered into a Definitive Merger Agreement (PR Newswire)
May-31-23 04:15PM Redwoods Acquisition Corp. Announces Receipt of Nasdaq Listing Delinquency Letter and Nasdaq Listing Compliance Determination Letter (PR Newswire)
May-30-23 06:00AM ANEW MEDICAL, INC. Enters Into Definitive Merger Agreement with Redwoods Acquisition Corp. (PR Newswire)
1234567⋯10⋯20
affiliate • advertise • toggle light mode • contact • privacy • help
do not sell my data • privacy settings
Quotes delayed 15 minutes for NASDAQ, NYSE and AMEX.
Copyright © 2007-2024 FINVIZ.com. All Rights Reserved.